Universal Biosensors (ASX:UBI) share price dips despite latest update

The Universal Biosensors Inc. (ASX: UBI) share price is edging lower today despite the company making further expansions overseas.

| More on:
A doctor looks unsure, indicating share price uncertainty for ASX medical companies

Image source: Getty images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Universal Biosensors Inc (ASX: UBI) share price is edging lower today. As of writing, shares in the medical diagnostics company are trading for 73 cents each, down 1.3%. By comparison, the S&P/ASX All Ordinaries Index (ASX: XAO) is 0.02% lower.

Today's price movement comes after the company announced another deal to distribute one of its products – this one in South Africa.

Let's take a closer look at today's news and what it means for the Universal Biosensors share price.

What's up with the Universal Biosensors share price?

In a statement to the ASX, Universal Biosensors advised it has entered a nonexclusive agreement with Vicard SA for the distribution of its wine testing platform device, Sentia, in South Africa. The deal is for 3 years.

Vicard SA is an importer of products necessary for wine production into South Africa. It has been in operation for more than 20 years.

This is the third such deal for the Sentia product. The company recently announced distribution deals in Chile and the United States. The Universal Biosensors share price rose 6% on the former deal and fell on the latter.

Sentia is a portable, wine-testing device that delivers results in less than 60 seconds. The test measures the amount of free sulphur dioxide present in a wine product. Free sulphur dioxide needs to be present in wine for bacterial stability.

Management commentary

Universal Biosensors CEO John Sharman said:

Securing distribution in South Africa is another step forward in the commercialisation of Sentia globally. Vicard SA has 20 years of experience supplying high quality resources to the South African wine industry and there are 500 wineries which will now have the opportunity to experience Sentia.

Along with the current capability we believe the possibility of Sentia's future testing capability for glucose, fructose, malic acid and others will add significant value to the winemaking industry. We are negotiating terms with a number of key industry players around the world and look forward to reporting additional distribution partnerships in due course.

Vicard SA CEO Michael Fernandez added:

I am thrilled to be bringing Sentia to the South African wine industry. The initial reaction from my customers has been very positive and they understand the unique benefits the system offers.

Universal Biosensors share price

Over the past 12 months, the Universal Biosensors share price has increased 279%. In fact, just over the last month, the company's value has appreciated 28.6%. On 9 April, the share price went up 36% in one day after a medical-related update.

The Universal Biosensors share price has a market capitalisation of $127.8 million.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares can rise 20% to 50%

Let's see which shares are being tipped to rocket from current levels.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors panicked when the latest inflation figures came out today.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why Guzman Y Gomez shares are a sell

Goldman Sachs has given its verdict on the burrito seller.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Mac Copper, Pro Medicus, Web Travel, and Yancoal shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

Man looking at his grocery receipt, symbolising inflation.
Share Market News

How are ASX 200 investors responding to the latest Aussie inflation numbers?

The ASX 200 was up 0.2% today before the ABS reported the latest inflation figures.

Read more »